Results 51 to 60 of about 33,978 (240)
Epidemiology and Risk Factors of Macrosomia
Background: The incidence of macrosomia is rising worldwide. This study aimed to investigate the epidemiological characteristics and risk factors of macrosomia in a specific region of China.
Guolin Liu +4 more
doaj +1 more source
Prevalence of abnormal birth weight and related factors in Northern region, Ghana [PDF]
Background: Birth weight is a crucial determinant of the development potential of the newborn. Abnormal newborn weights are associated with negative effects on the health and survival of the baby and the mother.
Abubakari, Abdulai +2 more
core +1 more source
Objective: To review the deliveries of macrocosmic babies and their obstetricaland neonatal outcomes. Methods: A prospective case control study involving a total of 3700deliveries at term of macrocosmic babies between Jan 2011 to Dec 2012 in Ziauddin HospitalKemari Campus.
Habiba Sharaf Ali, Shahina Ishtiaque
openaire +2 more sources
1,5-Anhydroglucitol as a marker of maternal glycaemic control and predictor of neonatal birthweight in pregnancies complicated by type 1 diabetes mellitus [PDF]
AIMS/HYPOTHESIS: Most pregnant women with type 1 diabetes mellitus achieve HbA(1c) targets; however, macrosomia remains prevalent and better pregnancy glycaemic markers are therefore needed.
B. Matejko +4 more
core +2 more sources
Background & Objectives: Macrosomia is a term applied to newborns with a birth weight more than of 4000 gr which cause different maternal and neonatal complications. Several risk factors has been known for macrosomia.
M Mardani +3 more
doaj
Background Currently, macrosomia contributes to maternal and neonatal morbidity and mortality in low—and middle-income countries because of changes in maternal lifestyle. Reliable data are needed for its prevention, early detection, and management.
Ikeola A. Adeoye +3 more
doaj +1 more source
Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews [PDF]
Background Successful treatments for gestational diabetes mellitus (GDM) have the potential to improve health outcomes for women with GDM and their babies. Objectives To provide a comprehensive synthesis of evidence from Cochrane systematic reviews of
Alsweiler, Jane +5 more
core +1 more source
Diabetes in pregnancy (DIP) is an increasing public health priority in the Australian Capital Territory, particularly due to its impact on risk for developing Type 2 diabetes.
A DeGaetano +21 more
core +1 more source
Gestational diabetes mellitus and macrosomia: An analysis of secondary data
Excessive fetal weight is considered as a health issues because it increases perinatal and maternal morbidity and mortality. The prevalence of macrosomia worldwide has increased over the past 2 to 3 decades.
Mufdlilah Mufdlilah, Fijri Rachmawati
doaj +1 more source
Macrosomia is a risk factor for incident maternal chronic kidney disease
Background Gestational diabetes mellitus (GDM) and macrosomia are associated with several adverse outcomes including diabetes mellitus and cardiovascular diseases, however, the relationship between GDM/macrosomia with incident chronic kidney disease (CKD)
Mohammad Vahidi +4 more
doaj +1 more source

